Although supported primarily by experimental and limited clinical data, the hypertriglyceridemia observed in chronic hypernatremia is likely multifactorial, with increased hepatic triglyceride secretion driven by hyperosmolality and the inhibition of lipoprotein lipase emerging as the most plausible mechanisms. The gene discussed is LPL; the disease is Hypernatremia.